Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

416 results

Treatment dilemma - how should we treat patients with multivessel disease

19 May 2022 – From EuroPCR 2022

Treatment dilemma - how

What's new in left main PCI - a closer look on the provisional vs. upfront two-stent strategy

19 May 2022 – From EuroPCR 2022

What's new in left main

Treatment dilemma: how should I treat an isolated CX or LAD stenosis

19 May 2022 – From EuroPCR 2022

Treatment dilemma: how

How should I treat ostial circumflex restenosis?

19 May 2022 – From EuroPCR 2022

Consider how to treat circumflex restenosis after a left main crossover stent and circumflex restenosis after left main PCI with 2 stents and try to learn from the two cases presented in this session: what are the ostial circumflex restenosis mechanisms, and the treatment options? What...

How should I treat ostial circumflex restenosis?

Facing left main PCI in your daily practice: learn from challenging situations

19 May 2022 – From EuroPCR 2022

Get an insight on left main PCI by learning from challenging scenarios: left main perforation, left main bifurcation PCI, complex tandem bifurcation lesions and many more!

Facing left main PCI in your daily practice: learn from challenging situations

PCI in complex high-risk patients: acute coronary syndrome and multivessel disease PCI

19 May 2022 – From EuroPCR 2022

Consider an 86-year-old man with acute chest pain and history of HTN, HLP, DM, renal insufficiency, peripheral artery disease, PTA, urocystic cancer, and TIA, and discuss how to treat this very complex patient combining all the problems we face every day in one person.

PCI in complex high-risk patients: acute coronary syndrome and multivessel disease PCI

Left main bifurcation stenting

19 May 2022 – From EuroPCR 2022

Let's study, LIVE from Massy, France, the case of a 76-year-old man, hypertensive, dyslipidemic, who presented apical necrosis without ischemia in 2017, asymptomatic, referred for myocardial scintigraphy, and find out more about performing LM PCI, using imaging to guide the procedure.

Left main bifurcation stenting

How to approach complex and calcified coronary lesions

19 May 2022 – From EuroPCR 2022

Discover the added value of imaging in complex left main PCI, the impact of robotization in severely calcified left main lesions and the use of directional rotational atherectomy for calcified nodule of left main bifurcation in these cases on complex and calcified coronary lesions!

How to approach complex and calcified coronary lesions

Left main PCI in different technical and anatomical scenarios

19 May 2022 – From EuroPCR 2022

Discover left main PCI in varied technical and anatomical situations, including the case of a left main intramural hematoma, of unprotected left main calcified stenosis and circumflex CTO, along with a case highlighting the importance of the kissing balloon technique.

Left main PCI in different technical and anatomical scenarios

Simplifying complex coronary interventions by adopting angiography-based physiology and a healing-targeted DES

19 May 2022 – From EuroPCR 2022

Consult this session to learn how to apply angio-based physiology to optimise patient selection for PCI, to discuss the impact of a healing-targeted DES on outcomes and DAPT duration, as well as to learn about the HT Supreme DES implantations in the (ongoing) QFR-guided, PIONEER IV trial.

Simplifying complex coronary